Related Experiment Video
Updated: Jun 21, 2025

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Biomarkers: how to consolidate them in clinical practice
María Jesús García de Yébenes Prous1, Loreto Carmona Ortells1
1Instituto de Salud Musculoesquelética (InMusc), Madrid, Spain.
Proper biomarker validation is crucial for accurate patient diagnosis and treatment. This work emphasizes correct analytical methods to ensure biomarker reliability and clinical utility.
Area of Science:
- Biomarker discovery and validation
- Clinical diagnostics
- Translational medicine
Background:
- Inadequate biomarker validation poses risks to patient diagnosis, treatment, and follow-up.
- Ensuring the accuracy of biomarker analyses is essential for clinical application.
- Generating evidence for the clinical utility of biomarkers is a key objective.
Purpose of the Study:
- To present a methodological framework for biomarker validation.
- To discuss challenges in biomarker development, validation, and clinical implementation.
- To highlight the importance of rigorous analytical approaches for biomarkers.
Main Methods:
- Conceptual review of biomarker validation principles.
- Analysis of methodological challenges in biomarker development.
- Discussion of strategies for clinical implementation of biomarkers.
Main Results:
- Identified critical steps and potential pitfalls in biomarker validation.
- Outlined the complexities in translating biomarkers from research to clinical practice.
- Emphasized the need for robust methodologies to ensure biomarker efficacy.
Conclusions:
- Rigorous biomarker validation is paramount for patient safety and effective healthcare.
- Addressing methodological challenges is key to successful biomarker implementation.
- Standardized validation processes are necessary to generate reliable clinical evidence.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

